kio-104
·Code: PP-001
kio-104: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Kiora Pharmaceuticals Inc. (KPRX) | Phase 2 |
| Kiora Pharmaceuticals Inc. (KPRX) | Phase 2 |
Clinical Trials (1)
A Phase 2, Open-label, Multiple Dose Study of the Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema (KLARITY-1)
Frequently asked questions
Who is developing kio-104?
kio-104 is being developed by Kiora Pharmaceuticals Inc..
How many clinical trials involve kio-104?
BioSniper tracks 1 clinical trial involving kio-104.
Get deeper analysis on kio-104
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis